Mauricio A. Berdugo, MD, MPH, is currently the Director of Medical Affairs at Humacyte, Inc. Mauricio has worked in different capacities within the CRO, pharma, diagnostics, and biotech industries in the USA and globally, including Latin America, Europe, and Asia over the past 9 years. His clinical and academic research stems from HIV/AIDS, cardiovascular disease, pulmonary disease, renal disease, and orthopedic spine surgery. Mauricio graduated from medical school at the Universidad Evangelica de El Salvador, completed his Master of Public Health degree from Kaplan University, and he is currently pursuing a Fellowship with the American College of Healthcare Executives.
- Mauricio Berdugo, Director of Medical Affairs at Humacyte, Inc ( Download)
- Yishan Chuang, PhD - Director, Scientific & Medical Affairs, Biodesix, Inc. ( Download)
- False aneurysm from alloprosthesithe Humacyte human acellular vessels. Treatment by trombin ( Download)
- ✨ WITI Hall of Fame Inductee ✨ Laura Niklason ( Download)
- How diversity, inclusion help one company turn sci-fi into sci-fact. With Juliana Blum, PhD. ( Download)
- Jon Lyons, PhD MBA - Director, Medical Affairs - U.S., Biofrontera, Inc. ( Download)
- False aneurysm from alloprosthesithe Humacyte human acellular vessels. Treatment by trombin ( Download)
- Overcoming hurdles associated with commercializing advanced therapies ( Download)
- Humacyte, Inc. (NASDAQ: HUMA) ( Download)
- Humacyte HAV | Richter ( Download)
- Laura Niklason - Inspiring Yale - GSAS ~ Sciences - 2015 ( Download)
- Human acellular vessels in coronary artery disease ( Download)
- The future of small-diameter human acellular vessels ( Download)
- VESS Winter Meeting 2022 Session 2 Talk 6 ( Download)
- Stock $HUMA / NASDAQ (Humacyte) | Trading Algorithm ( Download)
